Lightchain Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Lightchain Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 19, 2025	AI Proteins	$41.5M Series A	Steven Tregay, Omar H. Khalil	Cobro Ventures
Sep 1, 2025	Predicta Biosciences	$23.0M Series A	Ann DeWitt	BlueStone Venture Partners, The Engine, Ulu Ventures, Binney Street Capital, BrightEdge Ventures, Illumina Ventures, Mass General Brigham Ventures, Myeloma Solutions Fund
Aug 28, 2025	Wugen	$115.0M Other Equity	Fidelity Management & Research Company	Abingworth, Aisling Capital, Intermediate Capital Group, LYZZ Capital, Niall O'Donnell, Tybourne Capital Management
Feb 1, 2022	NextRNA Therapeutics	$47.0M Series A	Cobro Ventures, Drew Dennison, Lightchain Capital	Circle Alternative Investments, Evans Capital Management, Jefferies, Rivas Capital, Willett Advisors
Jan 1, 2022	AI Proteins	$18.0M Seed	Cobro Ventures, Drew Dennison	—
Jul 1, 2021	Wugen	$170.0M Series B	Abingworth, Bosun Hau	RiverVest, Aisling Capital, Alexandria Venture Investments, Falcon Edge Capital, Fidelity Management & Research Company, Peter Kiener, LYZZ Capital, John McKearn, Sands Capital, Velosity Capital
Jan 1, 2021	Mana Therapeutics	$35.0M Series A	Cobro Ventures, Drew Dennison	LifeSci Venture Partners
Jun 16, 2020	C4 Therapeutics, Inc.	$170.0M Debt / Series B	Todd Kaloudis, Adam Stone	3E Bioventures Capital, Adage Capital Management, Axil Capital, Bain Capital Life Sciences, Commodore Capital, HBM Healthcare Investments, Janus Henderson Investors, Logos Capital, Mizuho Securities Principal Investment, Nextech, RA Capital Management, RTW Investments, Sphera Funds Management, T. Rowe Price Associates, Yonjin Capital